Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

Eliem Therapeutics, Inc Common Stock (ELYM)

Pharmaceutical Preparations

https://www.eliemtx.com

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

2801 CENTERVILLE ROAD 1ST FLOOR, PMB #117
WILMINGTON, DE

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/10/2021

Market Cap

417,449,739

Shares Outstanding

27,570,000

Weighted SO

27,572,664

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

-0.3200

Last Div

0.0000

Range

2.35-11.55

Chg

0.1350

Avg Vol

189840

Mkt Cap

417449739

Exch

NASDAQ

Country

Phone

425 276 2300

DCF Diff

2.7649

DCF

3.4373

Div Yield

0.0000

P/S

0.0000

EV Multiple

-10.8968

P/FV

0.8500

Div Yield %

0.0000

P/E

-2.9430

PEG

-0.1205

Payout

0.0000

Current Ratio

60.4109

Quick Ratio

60.4109

Cash Ratio

59.6472

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0469

ROA

-0.2840

ROE

-0.4703

ROCE

-0.0803

NI/EBT

1.0000

EBT/EBIT

3.5982

EBIT/Rev

0.0000

Debt Ratio

0.0004

D/E

0.0004

LT Debt/Cap

0.0000

Total Debt/Cap

0.0004

Int Coverage

-15.5409

CF/Debt

0.5700

Equity Multi

1.0168

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

0.0019

FCF/Share

0.0019

Cash/Share

7.3523

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.5700

ST Coverage

0.5700

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.8500

P/B

0.8500

P/S

0.0000

P/E

-2.9430

P/FCF

7323.6796

P/OCF

3314.4916

P/CF

3314.4916

PEG

-0.1205

P/S

0.0000

EV Multiple

-10.8968

P/FV

0.8500

DPS

0.0000

Latest Headlines (EST)

Investing.com Jul 24, 03:21 Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells Shares By GuruFocus - Investing.com Canada ELYM Investing.com Jul 17, 03:57 Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ... By GuruFocus - Investing.com Canada ELYM Investing.com Jul 12, 05:19 Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells 105,931 Shares By GuruFocus - Investing.com Canada ELYM

Revenue Product Segmentation

Year	Purchases	Sales	Total Bought	Total Sold

Transaction Date	Name	Type Of Owner	Price	Securities Owned	Securities Transacted	Security Name	Transaction Type

Less Than 3 Months

0.00 Shares Bought (0 %)

0.00 Shares Sold (0%)

3 - 6 Months

5.00K Shares Bought (44.68 %)

6.19K Shares Sold (55.32%)

6 - 9 Months

19.91M Shares Bought (97.57 %)

495.53K Shares Sold (2.43%)

9 - 12 Months

57.85K Shares Bought (76.42 %)

17.85K Shares Sold (23.58 %)

Investor Name	Investment Discretion	Type of Security	Shares Owned	Avg Price Paid	Market Value	Change In Market Value	Change In Market Value (%)	Ownership	Weight

Date	Investors Holding	Closed Positions	Increased Positions	Reduced Positions	New Positions	Total Invested	Put/Call Ratio	Total Calls	Total Puts

Owner	Shares Owned

	2020	2022	2023	2024	2024	1970
Revenue	0.00	0.00	0.00	0.00	0.00
Cost Of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Gross Profit Ratio	0.00	0.00	0.00	0.00	0.00	▼
Research And Development Expenses	4.41M	▲ 6.88M	▼ 4.93M	▼ 3.13M	▼ 1.09M	▼
General And Administrative Expenses	1.54M	▲ 3.82M	▲ 4.63M	▼ 2.00M	▼ 1.91M	▼
Selling And Marketing Expenses	0.00	0.00	0.00	0.00	0.00
Selling General And Administrative Expenses	1.54M	▲ 3.82M	▲ 4.63M	▼ 2.00M	▼ 1.91M	▼
Other Expenses	0.00	▲ 60.00K	▲ 760.00K	▼ -2.26M	▲ 0.00
Operating Expenses	5.95M	▲ 10.70M	▼ 9.55M	▼ 5.12M	▼ 3.01M	▼
Cost And Expenses	5.95M	▲ 10.70M	▼ 9.55M	▼ 5.12M	▼ 3.01M	▼
Interest Income	0.00	0.00	▲ 360.00	▲ 1.35M	▼ 1.34M	▼
Interest Expense	0.00	0.00	▼ -2.82M	▲ 1.15M	▼ 0.00
Depreciation And Amortization	18.07M	▼ 370.00K	▼ -1.03M	▲ 3.06K	▲ 3.01M	▼
Ebitda	2.97M	▼ -10.80M	▲ -10.59M	▲ -5.12M	▲ -3.01M	▼
Ebitda Ratio	0.00	0.00	0.00	0.00	0.00	▼
Operating Income	-15.11M	▲ -10.70M	▲ -9.55M	▲ -5.12M	▲ -3.01M	▼
Operating Income Ratio	0.00	0.00	0.00	0.00	0.00	▼
Total Other Income Expenses Net	-8.91M	▲ 158.00K	▲ 1.79M	▼ 1.48M	▼ 1.31M	▼
Income Before Tax	-14.86M	▲ -10.55M	▲ -7.76M	▲ -3.64M	▲ -1.70M	▼
Income Before Tax Ratio	0.00	0.00	0.00	0.00	0.00	▼
Income Tax Expense	-9.16M	▲ -468.00K	▼ -1.79M	▲ -3.06K	▼ -3.01M	▼
Net Income	-14.86M	▲ -10.55M	▲ -5.97M	▲ -3.64M	▲ -1.70M	▼
Net Income Ratio	0.00	0.00	0.00	0.00	0.00	▼
Eps	-1.27	▲ -0.40	▲ -0.23	▲ -0.13	▲ -0.06	▼
Eps Diluted	-1.27	▲ -0.40	▲ -0.23	▲ -0.13	▲ -0.06	▼
Weighted Average Shs Out	11.66M	▲ 26.23M	▲ 26.37M	▲ 27.70M	▼ 27.64M	▼
Weighted Average Shs Out Dil	11.66M	▲ 26.23M	▲ 26.37M	▲ 27.70M	▼ 27.64M	▼